NCT06465589

Brief Summary

Social Anxiety Disorder (SAD) is one of the most widespread mental illnesses and it has previously been shown that online therapy and online self-help tools such as the one investigated in this study can be successful in reducing not only symptoms of SAD but also symptoms of depression and increase the quality of life of participants. A substantial concern with digital health intervention tools is data security and privacy as many such tools have been found to be unsafe and easy targets for hacker attacks, potentially endangering personal (health) data of the users. For this research project, an internet-based program targeting social anxiety has been developed that can be used completely anonymously (i.e., without collecting an email address or other information that can or could potentially identify users). This new anonymized version will be compared in a partially randomized patient preference trial with an already well-evaluated version in which, as is common in other digital health applications, personal data such as the email address or other information from the users is used, for example, for login. Study objectives:

  1. 1.To investigate the efficacy of a completely anonymous version of the program "JOURNeY" based on cognitive behavioral therapy (CBT) and compare it to an already evidence-based non-anonymous version of the program regarding primary social anxiety symptoms, and secondary outcomes such as depressive symptoms, quality of life, usability, adherence to the program, internalized stigma, attitudes on help-seeking, and personality functioning.
  2. 2.To investigate patients' preferences and the influence of patients' preferences on outcome.
  3. 3.To explore how patient characteristics are associated with participants' preferences.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
452

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 13, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 20, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

September 3, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 2, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 2, 2026

Completed
Last Updated

April 20, 2026

Status Verified

April 1, 2026

Enrollment Period

1.5 years

First QC Date

June 13, 2024

Last Update Submit

April 15, 2026

Conditions

Keywords

Social AnxietyMental DisordersInternet InterventionSelf HelpPreference

Outcome Measures

Primary Outcomes (1)

  • Social Anxiety Symptoms

    Change from baseline in the composite score of two self-report social anxiety questionnaires measuring various symptoms from time pre to time post (Social Phobia Scale \& Social Interaction Anxiety Scale; SPS \& SIAS). The scales contain a total of 40 items resulting in scores of 0 to 160 with higher scores indicating more severe social anxiety symptoms. The composite score will be the averaged z-score of both questionnaires.

    at baseline, 8 Weeks

Secondary Outcomes (6)

  • Social Anxiety Symptoms

    at baseline, at 8 weeks, at 24 weeks

  • Depressive Symptoms

    at baseline, at 8 weeks, at 24 weeks

  • Quality of Life QoL

    at baseline, at 8 weeks, at 24 weeks

  • Internalized Stigma

    at baseline, at 8 weeks, at 24 weeks

  • Attitudes Towards Help-Seeking

    at baseline, at 8 weeks, at 24 weeks

  • +1 more secondary outcomes

Study Arms (4)

Randomized Anonymous

EXPERIMENTAL

After participants are randomized to the randomization arm, they will once again be randomized to the program versions. Participants in this arm will use the anonymous program.

Other: JOURNeY anonymous

Randomized Standard

ACTIVE COMPARATOR

After participants are randomized to the randomization arm, they will once again be randomized to the program versions. Participants in this arm will use the standard program.

Other: JOURNeY standard

Preferred Anonymous

OTHER

After participants are randomized to the preference arm, they will be given access to the program version they indicate a preference for after having read two descriptive texts about both versions. Participants in this arm will use the anonymous program.

Other: JOURNeY anonymous

Preferred Standard

OTHER

After participants are randomized to the preference arm, they will be given access to the program version they indicate a preference for after having read two descriptive texts about both versions. Participants in this arm will use the standard program.

Other: JOURNeY standard

Interventions

The anonymously usable version of the self-help program JOURNeY which does not require a login and does not collect personal data. Includes 4 main components: 1. psychoeducation where participants learn about SAD and the treatment, 2. cognitive restructuring where participants challenge dysfunctional social cognitions, 3. attention training where participants learn to decrease self-focused attention, and 4. exposure where participants seek out and endure fear-inducing situations. Additionally, there is a first module which discusses motivation and a conclusion module which encourages participants to keep practicing and using techniques they learned in the program in their daily life.

Preferred AnonymousRandomized Anonymous

The standard version of the self-help program JOURNeY which requires a login and collects personal data. Includes 4 main components: 1. psychoeducation where participants learn about SAD and the treatment, 2. cognitive restructuring where participants challenge dysfunctional social cognitions, 3. attention training where participants learn to decrease self-focused attention, and 4. exposure where participants seek out and endure fear-inducing situations. Additionally, there is a first module which discusses motivation and a conclusion module which encourages participants to keep practicing and using techniques they learned in the program in their daily life.

Preferred StandardRandomized Standard

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Written informed consent
  • Be 18 years or older,
  • Have access to the internet
  • Have access to a smartphone, computer or tablet
  • Score 22 points or higher on the Social Phobia Scale or 33 points or higher on the Social Interaction Anxiety Scale (SPS \& SIAS)

You may not qualify if:

  • Score 2 points or higher on the suicide item of the PHQ-9
  • Have previously been diagnosed with psychotic symptoms or bipolar disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Bern, Clinical Psychology and Psychotherapy Department

Bern, 3012, Switzerland

Location

Related Publications (20)

  • Clark, D. M., & Wells, A. (1995). A cognitive model of social phobia. In R. G. Heimberg, M. R. Liebowitz, D. Hope, & F. Schneider (Eds.), Social Phobia: Diagnosis, Assessment, and Treatment (pp. 69-93). Guilford Press.

    BACKGROUND
  • Schulz A, Stolz T, Vincent A, Krieger T, Andersson G, Berger T. A sorrow shared is a sorrow halved? A three-arm randomized controlled trial comparing internet-based clinician-guided individual versus group treatment for social anxiety disorder. Behav Res Ther. 2016 Sep;84:14-26. doi: 10.1016/j.brat.2016.07.001. Epub 2016 Jul 7.

    PMID: 27423374BACKGROUND
  • Sibitz I, Friedrich ME, Unger A, Bachmann A, Benesch T, Amering M. [Internalized Stigma of Schizophrenia: Validation of the German Version of the Internalized Stigma of Mental Illness-Scale (ISMI)]. Psychiatr Prax. 2013 Mar;40(2):83-91. doi: 10.1055/s-0032-1332878. Epub 2013 Jan 25. German.

    PMID: 23354628BACKGROUND
  • Stolz T, Schulz A, Krieger T, Vincent A, Urech A, Moser C, Westermann S, Berger T. A mobile app for social anxiety disorder: A three-arm randomized controlled trial comparing mobile and PC-based guided self-help interventions. J Consult Clin Psychol. 2018 Jun;86(6):493-504. doi: 10.1037/ccp0000301.

    PMID: 29781648BACKGROUND
  • Gräfe, K., Zipfel, S., Herzog, W., & Löwe, B. (2004). Screening psychischer Störungen mit dem "Gesundheitsfragebogen für Patienten (PHQ-D)". Diagnostica, 50(4), 171-181. https://doi.org/10.1026/0012-1924.50.4.171

    BACKGROUND
  • Berger T, Caspar F, Richardson R, Kneubuhler B, Sutter D, Andersson G. Internet-based treatment of social phobia: a randomized controlled trial comparing unguided with two types of guided self-help. Behav Res Ther. 2011 Mar;49(3):158-69. doi: 10.1016/j.brat.2010.12.007. Epub 2011 Jan 1.

    PMID: 21255767BACKGROUND
  • Kessler EM, Agines S, Bowen CE. Attitudes towards seeking mental health services among older adults: personal and contextual correlates. Aging Ment Health. 2015;19(2):182-91. doi: 10.1080/13607863.2014.920300. Epub 2014 Jun 5.

    PMID: 24898327BACKGROUND
  • Wolfangel, E. (2023, May 9). Datenschutz: Wenn Hacker mit Gesundheits-Apps besonders leichtes Spiel haben. ZEIT ONLINE. https://www.zeit.de/digital/datenschutz/2023-05/gesundheitsapp-datenschutz-depression-edupression-sicherheitsluecke/komplettansicht

    BACKGROUND
  • Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998 Nov;51(11):1171-8. doi: 10.1016/s0895-4356(98)00109-7.

    PMID: 9817135BACKGROUND
  • Batterham P, Gulliver A, Sunderland M, Farrer L, Kay-Lambkin F, Trias A, Calear A. Factors Influencing Community Participation in Internet Interventions Compared With Research Trials: Observational Study in a Nationally Representative Adult Cohort. J Med Internet Res. 2023 Feb 2;25:e41663. doi: 10.2196/41663.

    PMID: 36729613BACKGROUND
  • Spitzer C, Muller S, Kerber A, Hutsebaut J, Brahler E, Zimmermann J. [The German Version of the Level of Personality Functioning Scale-Brief Form 2.0 (LPFS-BF): Latent Structure, Convergent Validity and Norm Values in the General Population]. Psychother Psychosom Med Psychol. 2021 Jul;71(7):284-293. doi: 10.1055/a-1343-2396. Epub 2021 Mar 10. German.

    PMID: 33694153BACKGROUND
  • Stein DJ, Lim CCW, Roest AM, de Jonge P, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Benjet C, Bromet EJ, Bruffaerts R, de Girolamo G, Florescu S, Gureje O, Haro JM, Harris MG, He Y, Hinkov H, Horiguchi I, Hu C, Karam A, Karam EG, Lee S, Lepine JP, Navarro-Mateu F, Pennell BE, Piazza M, Posada-Villa J, Ten Have M, Torres Y, Viana MC, Wojtyniak B, Xavier M, Kessler RC, Scott KM; WHO World Mental Health Survey Collaborators. The cross-national epidemiology of social anxiety disorder: Data from the World Mental Health Survey Initiative. BMC Med. 2017 Jul 31;15(1):143. doi: 10.1186/s12916-017-0889-2.

    PMID: 28756776BACKGROUND
  • Mattick RP, Clarke JC. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behav Res Ther. 1998 Apr;36(4):455-70. doi: 10.1016/s0005-7967(97)10031-6.

    PMID: 9670605BACKGROUND
  • Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999 Nov 10;282(18):1737-44. doi: 10.1001/jama.282.18.1737.

    PMID: 10568646BACKGROUND
  • Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996 Mar;34(3):220-33. doi: 10.1097/00005650-199603000-00003.

    PMID: 8628042BACKGROUND
  • Ritsher JB, Otilingam PG, Grajales M. Internalized stigma of mental illness: psychometric properties of a new measure. Psychiatry Res. 2003 Nov 1;121(1):31-49. doi: 10.1016/j.psychres.2003.08.008.

    PMID: 14572622BACKGROUND
  • Mackenzie, C. S., Knox, V. J., Gekoski, W. L., & Macaulay, H. L. (2004). An Adaptation and Extension of the Attitudes Toward Seeking Professional Psychological Help Scale1. Journal of Applied Social Psychology, 34(11), 2410-2433. https://doi.org/10.1111/j.1559-1816.2004.tb01984.x

    BACKGROUND
  • Hutsebaut J, Feenstra DJ, Kamphuis JH. Development and Preliminary Psychometric Evaluation of a Brief Self-Report Questionnaire for the Assessment of the DSM-5 level of Personality Functioning Scale: The LPFS Brief Form (LPFS-BF). Personal Disord. 2016 Apr;7(2):192-7. doi: 10.1037/per0000159. Epub 2015 Nov 23.

    PMID: 26595344BACKGROUND
  • Weekers LC, Hutsebaut J, Kamphuis JH. The Level of Personality Functioning Scale-Brief Form 2.0: Update of a brief instrument for assessing level of personality functioning. Personal Ment Health. 2019 Feb;13(1):3-14. doi: 10.1002/pmh.1434. Epub 2018 Sep 19.

    PMID: 30230242BACKGROUND
  • Arnold S, Vogt MF, Boettcher J, Fenski F, Sipka D, Elson M, Berger T. A Freely Accessible, Anonymous Online Treatment for Social Anxiety: Protocol for a Partially Randomized Patient Preference Trial. JMIR Res Protoc. 2025 Nov 5;14:e77573. doi: 10.2196/77573.

Related Links

MeSH Terms

Conditions

Mental Disorders

Study Officials

  • Thomas Berger, Prof. Dr.

    University Bern, Clinical Psychology and Psychotherapy Department

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
The investigators will not know which specific condition the participants were in for the initial analysis. The blind will be broken for the investigators after first interpretation of the results.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study is a single-center partially randomized patient preference trial with four conditions (program version: standard vs. anonymous and allocation: randomized vs. preferred)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 13, 2024

First Posted

June 20, 2024

Study Start

September 3, 2024

Primary Completion

March 2, 2026

Study Completion

March 2, 2026

Last Updated

April 20, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations